A research team under the guidance of Dr. Andrew Godwin was awarded a grant of 11.4 million for five years by the Centers for Biomedical Research Excellence (COBRE) to set up an institute at the University of Kansas Medical Center for Precision Medicine.
“Precision medicine has the potential to change the landscape of how we provide care,” said Mr. Robert Simari. “Receiving a grant of this size is remarkable and will enable our researchers to develop tailored treatments for all types of diseases. This approach aligns with the university’s mission to improve lives through innovation in research and health care.”
Kansas Institute for Precision Medicine (KIPM) aims to advance the utilization of precision medicine that is an approach to observe individual differences in genes of people, their environments and their lifestyles in order to identify therapies that would be effective.
Roy Jensen, the director at Cancer Centre in KU said, “The University of Kansas Cancer Center has made precision medicine a research priority. With this grant, our efforts are strengthened and we can infuse the concept of precision medicine throughout our institution and region,”
The COBRE grant will also allow the research team to construct a mentoring program that will be led by a physician and scientist Mr. Alan Yu that will prepare young investigators to participate successfully for further NIH grants for research. These grants can be renewed three times, representing roughly thirty-four million dollars for funding and supporting many junior and also some seasoned investigators via pilot grants.
“Our success will ultimately be measured by the number of early-career investigators who successfully develop independently NIH-funded research programs,” Dr. Godwin said. “As team members are funded, we will recruit new trainees. Over time, using the various funding mechanisms available through the KIPM COBRE, our pool of precision medicine experts will grow.”